HIV-1 Triggers Apoptosis in Primary Osteoblasts and HOBIT Cells Through TNFalpha Activation
Overview
Authors
Affiliations
Several HIV-1 infected patients show bone loss and osteopenia/osteoporosis during the course of disease. The mechanisms underlying this degenerative process are largely unsettled and it has not been determined yet whether bone dysfunction is linked to HIV-1-mediated direct and/or indirect effects on osteoblasts/osteoclasts cross-talk regulation. This study investigated the effects of HIV-1(IIIb) and HIV-1(ADA) strains on osteoblasts using the osteoblast-derived cell line (HOBIT) and primary human osteoblasts as cellular models. The challenge of these cell cultures by both HIV-1 strains triggered a significant apoptosis activation unrelated to viral infection, since proviral HIV-1 DNA and supernatant HIV-1 RNA were not detected by real time PCR or b-DNA assays respectively. Under the experimental conditions, even heat-inactivated HIV-1 or cross-linked recombinant gp120 treatment of HOBIT and osteoblasts induced programmed cell death, suggesting that apoptosis is regulated by the interaction between HIV-1 gp120 and cell membrane. The analysis of cell culture supernatants showed a significant up-regulation of TNFalpha, a pleiotropic protein considered an apoptosis inducer in the osteoblast model. In fact, pretreatment of HOBIT and osteoblast cell cultures with anti-TNFalpha polyclonal antibody tackled effectively HIV-1 related induction of cell apoptosis. As a whole, these results indicate that HIV-1 may impair bone mass structure homeostasis by TNFalpha regulated osteoblast apoptosis.
Azarboo A, Hemmatabadi M, Fahimfar N, Faghihi Z, SeyedAlinaghi S, Shirzad N BMC Infect Dis. 2025; 25(1):33.
PMID: 39762767 PMC: 11706035. DOI: 10.1186/s12879-024-10388-y.
Furlani F, Malfatti M, Rondinella A, Campodoni E, Sandri M, Fedrizzi L J Biol Eng. 2024; 18(1):60.
PMID: 39456111 PMC: 11515322. DOI: 10.1186/s13036-024-00458-9.
HIV Modulates Osteoblast Differentiation via Upregulation of RANKL and Vitronectin.
Freiberger R, Lopez C, Palma M, Cevallos C, Sviercz F, Jarmoluk P Pathogens. 2024; 13(9).
PMID: 39338991 PMC: 11435243. DOI: 10.3390/pathogens13090800.
Jadzic J, Dragovic G, Lukic R, Obradovic B, Djuric M J Pers Med. 2024; 14(8).
PMID: 39201983 PMC: 11355540. DOI: 10.3390/jpm14080791.
Consequences of HIV infection in the bone marrow niche.
Herd C, Mellet J, Mashingaidze T, Durandt C, Pepper M Front Immunol. 2023; 14:1163012.
PMID: 37497228 PMC: 10366613. DOI: 10.3389/fimmu.2023.1163012.